1. Home
  2. PRT vs NMTC Comparison

PRT vs NMTC Comparison

Compare PRT & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PermRock Royalty Trust Trust Units

PRT

PermRock Royalty Trust Trust Units

HOLD

Current Price

$2.43

Market Cap

27.7M

Sector

Energy

ML Signal

HOLD

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$2.16

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRT
NMTC
Founded
2017
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
29.2M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
PRT
NMTC
Price
$2.43
$2.16
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.90
AVG Volume (30 Days)
46.7K
49.3K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
13.45%
N/A
EPS Growth
N/A
80.43
EPS
N/A
N/A
Revenue
N/A
$9,097,692.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$31.90
P/E Ratio
$7.78
N/A
Revenue Growth
N/A
163.47
52 Week Low
$1.82
$0.55
52 Week High
$4.14
$5.40

Technical Indicators

Market Signals
Indicator
PRT
NMTC
Relative Strength Index (RSI) 59.95 25.85
Support Level $1.87 $0.67
Resistance Level $3.62 $3.41
Average True Range (ATR) 0.10 0.25
MACD 0.02 -0.06
Stochastic Oscillator 93.53 3.49

Price Performance

Historical Comparison
PRT
NMTC

About PRT PermRock Royalty Trust Trust Units

PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: